skip to main content

HFrEF — EECC MCQ

Instant feedback + full explanation. One question, done properly.

HardHeart FailureHFrEFEECC

A man with HFrEF takes sacubitril/valsartan, bisoprolol and dapagliflozin. eGFR is 42 mL/min/1.73 m² and potassium is 5.2 mmol/L on two non-haemolysed samples. He is euvolaemic. Which is the best next step when considering an MRA?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: ECorrect potassium before carefully introducing an MRA

An MRA is a prognostic HFrEF treatment, but potassium already above the usual initiation threshold requires correction and a monitored plan rather than reflex prescribing. Review supplements, salt substitutes, NSAIDs, diet, renal function and volume status. In an appropriate patient, patiromer or sodium zirconium cyclosilicate may enable prognostic therapy. Repeat potassium soon after any intervention and after MRA initiation or titration. Stopping every disease-modifying drug unnecessarily also worsens heart-failure risk.

Reference: 2023 ESC focused update on heart failure. https://www.escardio.org/guidelines/clinical-practice-guidelines/focused-update-on-heart-failure-guidelines/